Location History:
- Saitama, JP (2010 - 2011)
- Minami-saitama-gun, JP (2008 - 2016)
Company Filing History:
13 out of 1,235 
1 out of 6 Years Active: 2008-2016
Title: The Innovative Contributions of Norihisa Ishiwata
Introduction
Norihisa Ishiwata, an accomplished inventor from Minamisaitama-gun, Japan, has made significant contributions in the field of hematopoietic stem cell research. With a portfolio of 13 patents to his name, Ishiwata is recognized for his innovative methods that aim to improve treatments for various hematopoietic disorders.
Latest Patents
Among his latest inventions is a method for expanding hematopoietic stem cells using heterocyclic compounds. This invention provides an expansion agent for hematopoietic stem cells, which enhances gene transfer efficiency into these cells, paving the way for effective gene therapy options. The method describes culturing hematopoietic stem cells and/or progenitor cells ex vivo in the presence of specific compounds, which are chemically defined within his patent documentation.
Moreover, Ishiwata has focused on expanding CD34 cells ex vivo in a biologically safe and cost-effective manner. His method seeks to utilize low molecular weight compounds that can efficiently increase the quantity of CD34 cells, which are essential for the treatment of hematopoietic disorders stemming from dysfunctional stem cells.
Career Highlights
Ishiwata's career has been marked by impactful roles at reputable companies. He has contributed significantly while working at Nissan Chemical Industries Limited and Reprocell, Inc., where he further refined his expertise in stem cell research and innovative therapeutic solutions.
Collaborations
Throughout his career, Norihisa Ishiwata has collaborated with notable professionals in his field, including coworkers Katsuaki Miyaji and Yutaka Hirokawa. These collaborations have likely enriched his research and expanded the scope of his innovations in hematopoietic stem cell applications.
Conclusion
Norihisa Ishiwata exemplifies the spirit of innovation with his work centered on hematopoietic stem cells. Through his patents, he has not only contributed to scientific understanding but also provided tangible methods that can improve treatments for blood-related disorders. His ongoing dedication to research and collaboration continues to hold promise for future advancements in the field.